Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Retained Earnings (2024 - 2025)

Carlsmed (CARL) has disclosed Retained Earnings for 2 consecutive years, with -$100.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 41.64% year-over-year to -$100.8 million, compared with a TTM value of -$100.8 million through Dec 2025, down 41.64%, and an annual FY2025 reading of -$100.8 million, down 41.64% over the prior year.
  • Retained Earnings was -$100.8 million for Q4 2025 at Carlsmed, down from -$92.2 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$71.2 million in Q4 2024 and bottomed at -$100.8 million in Q4 2025.